Filing Details
- Accession Number:
- 0001209191-21-018051
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-03-05 06:08:48
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-05 06:08:48
- Original Submission Date:
- 2021-03-03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1687436 | Jan Mattsson | C/O Albireo Pharma Inc. 10 Post Office Square, Suite 1000 Boston MA 02109 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-01 | 39,330 | $1.00 | 69,044 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 15,300 | $37.45 | 53,744 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-02 | 12,351 | $36.07 | 41,393 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-02 | 612 | $36.54 | 40,781 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-02 | 2,807 | $37.15 | 37,974 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-03 | 400 | $36.20 | 37,574 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 39,330 | $0.00 | 39,330 | $1.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-18 | No | 4 | M | Direct |
Footnotes
- Represents 63,544 shares of common stock and 5,500 restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents 48,244 shares of common stock and 5,500 restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents 35,893 shares of common stock and 5,500 restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents 35,281 shares of common stock and 5,500 restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents 32,474 shares of common stock and 5,500 restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents 32,074 shares of common stock and 5,500 restricted stock units.
- This option is fully vested.
Billionaire Hedge Funds
